GASTALDI, SIMONE

GASTALDI, SIMONE  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autore(i) File
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 2018 Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Laura Benvenuti, Vanessa D’Antongiovanni, Gianfranco Natale, Federica Fulceri, Marta Giorgis, Elisabetta Marini, Simone Gastaldi, Massimo Bertinaria, Corrado Blandizzi, Luca Antonioli
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor 2021 Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M.
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 2021 BLANDIZZI CORRADO, PELLEGRINI CAROLINA, FORNAI MATTEO, ANTONIOLI LUCA, COLUCCI ROCCHINA, BERTINARIA MASSIMO, MARINI ELISABETTA, BOSCARO VALENTINA, GASTALDI SIMONE, COCCO MATTIA
Covalent NLRP3 inhibitors: design strategies, synthesis and pharmacological characterization 2018 Gastaldi S., Introvigne M.L., Marino M., Marini E., Bertinaria M. Giorgis M.
Design and synthesis of encorafenib-based BRAF-V600E degraders 2022 Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Development of covalent NLRP3 inflammasome inhibitors: chemistry and biological activity 2019 Bertinaria Massimo, Gastaldi Simone, Marini Elisabetta, Giorgis Marta
EVALUATION OF THE ANTIPYROPTOTIC ACTIVITY OF NEW INFLAMMASOME INHIBITORS 2021 Boscaro Valentina, Gastaldi Simone, Bertinaria Massimo, Gallicchio Margherita
In silico study of NLRP3: towards selective inhibition with small molecules 2019 Alejandro Gómez García, Simone Gastaldi, Giulia Fumero, Massimo Bertinaria, José Luis Medina Franco
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold 2021 Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F. Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A. MacDonald, Massimo Bertinaria
Inflammasome Biology Fundamentals, Role in Disease States, and Therapeutic Opportunities 2022 Massimo Bertinaria, Simone Gastaldi, Elisabetta Marini
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases 2019 Simone Gastaldi, Federica Blua, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 2022 Marini, Elisabetta; Marino, Marco; Gionfriddo, Giulia; Maione, Federica; Pandini, Marta; Oddo, Daniele; Giorgis, Marta; Rolando, Barbara; Blua, Federica; Gastaldi, Simone; Marchiò, Serena; Kovachka, Sandra; Spyrakis, Francesca; Gianquinto, Eleonora; Di Nicolantonio, Federica; Bertinaria, Massimo
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY 2019 Gastaldi, S; Marino, M.; Giorgis, M.; Marini, E.; Boscaro, V.; Gallicchio, M.; Bertinaria, M.
Pharmacological characterization of new NLRP3 inflammasome inhibitors. 2019 Valentina Boscaro, Simone Gastaldi, Marco Marino, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria, Margherita Gallicchio
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity 2019 Elisabetta Marini, Simone Gastaldi, Marta Giorgis, Marco Marino, Valentina Boscaro, Margherita Gallicchio, Massimo Bertinaria